Abstract
APCs are key players in the induction of T-cell responses. Accordingly, they have gained much attention as therapeutic targets for inflammatory diseases and cancer. Understanding their mode of action could serve in revealing novel approaches for the induction and blockade of T-cell immunity. This meeting has focused on recent advances in inducing the tolerogenic and immunostimulatory function of dendritic cells as well as current progress in the understanding of dendritic cell suppression through the CD4+ Treg cell function.
Financial & competing interests disclosure
N Nicolaou would like to acknowledge financial support for attendance at this meeting from EuroSciCon. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.